Rights and permissions
About this article
Cite this article
Somatropin lowers serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) levels in patients without cachexia who have moderate heart failure associated with coronary artery disease. Inpharma Wkly. 1236, 19 (2000). https://doi.org/10.2165/00128413-200012360-00047
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012360-00047